Salmonella enterica serovar typhimurium infection induces cyclooxygenase 2 expression in macrophages: Involvement of Salmonella pathogenicity island 2

Infection and Immunity

Volumn 72, Issue 12, 2004, Pages 6860-6869

  Uchiya, Kei Ichi ^a   Nikai, Toshiaki ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTANOID;

ANIMAL CELL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE MUTATION; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SALMONELLA ENTERICA; SALMONELLA PATHOGENICITY ISLAND 2; SALMONELLOSIS; SEROTYPE; SIGNAL TRANSDUCTION; SPIC GENE;

ANIMALS; BACTERIAL PROTEINS; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME ACTIVATION; EPOPROSTENOL; ISOENZYMES; MACROPHAGES; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION;

EID: 9244235537     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.12.6860-6869.2004     Document Type: Article

References (52)

1. Arakawa, T., O. Laneuville, C. A. Miller, K. M. Lakkides, B. A. Wingerd, D. L. DeWitt, and W. L. Smith. 1996. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells: structure and expression of the murine prostaglandin EP4 receptor gene. J. Biol. Chem. 271:29569-29575.
2. Astiz, M., D. Saha, D. Lustbader, R. Lin, and E. Rackow. 1996. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J. Lab. Clin. Med. 128:594-600.
3. phox in human neutrophils: a possible pathway for inhibition of the respiratory burst. Cell Signal. 8:291-296.
4. Bogdan, C., Y., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann. N. Y. Acad. Sci. 685:713-739.
5. Chakravortty, D., I. H. Wester, and M. Hensel. 2002. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 195:1155-1166.
6. Chen, B. C., Y. H. Chen, and W. W. Lin. 1999. Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 97:124-129.
7. Chen, C. C., Y. T. Sun, J. J. Chen, and Y. J. Chang. 2001. Tumor necrosis factor-α-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IκB kinase 1/2 in human alveolar epitherial cells. Mol. Pharmacol. 59:493-500.
8. Cirillo, D. M., R. H. Valdivia, D. M. Monack, and S. Falkow. 1998. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol. Microbiol. 30:175-188.
9. Coleman, R. A., I. Kennedy, P. P. A. Humphrey, K. Bunce, and P. Lumley. 1990. Prostanoid and their receptors, p. 643-714. In C. Hansch, P. G. Sammes, J. B. Taylor, and J. C. Emmett (ed.), Comprehensive medical chemistry, 2nd ed. Pergamon, Oxford, England.
10. Coleman, R. A., W. L. Smith, and S. Narumiya. 1994. Classification of prostanid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:205-229.
11. Dean, J. L. E., M. Brook, A. R. Clark, and J. Saklatvala. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:264-269.
12. Farrell, J. P., and C. E. Kirkpatrick. 1987. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania mayor-infected BALB/c mice. J. Immunol. 138:902-907.
13. Freeman, J. A., C. Rapple, V. Kuhle, M. Hensel, and S. I. Miller. 2002. SpiC is required for translocation of Salmonella pathogenicity island 2 effectors and secretion of translocon protein SseB and SseC. J. Bacteriol. 184:4971-4980.
14. Gabig, T. G., C. D. Cren, P. L. Mantel, and R. Rosli. 1995. Function of wild-type or mutant Rac2 and Rap1a GTPases in differentiated HL60 cell NADPH oxidase activation. Blood 85:804-811.
15. Gallois, A., J. R. Klein, L. A. Allen, B. D. Jones, and W. M. Nauseef. 2001. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J. Immunol. 166:5741-5748.
16. German, R. R., F. A. Fitzpatrick, and O. V. Miller. 1978. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin. Adv. Cyclic Nucleotide Res. 9:597-609.
17. Groisman, E. A., A.-B. Blanc-Portard, and K. Uchiya. 1999. Pathogenicity island and the evolution of Salmonella virulence, p. 127-150. In J. B. Kaper and J. Hacker (ed.), Pathogenicity island and other mobile virulence elements. ASM Press, Washington, D.C.
18. Guan, Z., S. Y. Buckman, A. P. Pentland, D. J. Templeton, and A. R. Morrison. 1998. Induction of cyclooxygenase-2 by the activated MEKK1-→SEK/MKK4-→p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 273:12901-12908.
19. Halushka, P. V., Mais, D. E., P. R. Mayeux, and T. A. Morinelli. 1989. Thromboxane, prostaglandin and leukotriene receptors. Annu. Rev. Pharmacol. Toxicol. 29:213-239.
20. Hensel, M., J. E. Shea, S. R. Waterman, R. Mundy, T. Nikolaus, G. Banks, A. Vazquez-Torres, C. Gleeson, F. C. Fang, and D. W. Holden. 1998. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 30:163-174.
21. Ichikawa, A., Y. Sugimoto, and A. Negishi. 1996. Molecular aspects of the structures and functions of the prostaglandin E receptors. J. Lipid Mediat. Cell Signal. 14:83-87.
22. 4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages. J. Immunol. 166:4689-4696.
23. 4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. Biochem. Biophys. Res. Commun. 251:727-731.
24. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263:5380-5384.
25. 2. Biochem. Biophys. Res. Commun. 137:404-410.
26. Lee, A. H., M. P. Zareei, and S. Daefler. 2002. Identification of a NIPSNAP homologue as host cell target for Salmonella virulence protein SpiC. Cell Microbiol. 4:739-750.
27. Lee, S. H., E. Soyoola, P. Chanmugam, S. Hart, W. Sun, H. Zhong, S. Liou, D. Simmons, and D. Hwang. 1992. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267:25934-25938.
28. Lo, C. J. 2003. MAPK regulation of prostaglandin E2 production by lipopolysaccharide-stimulated macrophages is not dependent on nuclear factor κB. J. Surg. Res. 113:189-194.
29. Marotta, P., L. Sautebin, and M. Di Rosa. 1992. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107:640-641.
30. 2 synthesis. Parasite Immunol. 23:177-184.
31. 2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49:105-115.
32. Namba, T., H. Oida, Y. Sugimoto, A. Kakizuka, M. Negishi, A. Ichikawa, and S. Narumiya. 1994. cDNA cloning of a mouse prostacyclin receptor-multiple signaling pathways and expression in thymic medulla. J. Biol. Chem. 269: 9986-9992.
33. Narumiya, S., Y. Sugimoto, and F. Ushikubo. 1999. Prostanoid receptors: structure, properties and functions. Physiol. Rev. 79:1193-1226.
34. Nathan, C. R., H. W. Murray, M. E. Wiebe, and B. Y. Rubin. 1983. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670-689.
35. O'Banion, M. K., V. D. Winn, and D. A. Young. 1992. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA 89:4888-4892.
36. Ochman, H., F. C. Soncini, F. Solomon, and E. A. Groisman. 1996. Identification of a pathogenicity island required for Salmonella survival in host cells. Proc. Natl. Acad. Sci. USA 93:7800-7804.
37. Phipps, R. P., S. H. Stein, and R. L. Roper. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12:349-352.
38. Pouliot, M., J. Baillargeon, J. C. Lee, L. G. Cleland, and M. J. James. 1997. Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. J. Immunol. 158:4930-4937.
39. Qilliam, L., H. Mueller, B. Bohl, V. Prossnitz, L. Sklar, C. Der, and G. Bokoch. 1991. Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J. Immunol. 147:1628-1635.
40. Reiner, N. E., and C. J. Malemud. 1984. Arachidonic acid metabolism in murine leishmaniasis (donovani): ex-vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells. Cell. Immunol. 88:501-510.
41. Shea, J. E., M. Hensel, C. Gleeson, and D. W. Holden. 1996. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 93:2593-2597.
42. Sheng, H., C. S. Williams, J. Shao, P. Liang, R. N. DuBois, and R. D. Beauchamp. 1998. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem. 273:22120-22127.
43. Shotland, Y., H. Krämer, and E. A. Groisman. 2003. The Salmonella SpiC protein targets the mammalian Hook3 protein function to alter cellular trafficking. Mol. Microbiol. 49:1565-1576.
44. Smith, W. L., and L. J. Marnett. 1991. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim. Biophys. Acta 1083:1-17.
45. 2. J. Exp. Med. 180:2365-2370.
46. 2 protects against liver injury after Eschenchia coli infection but hampers the resolution of the infection in mice. J. Immunol. 161:3019-3025.
47. Uchiya, K., M. A. Barbieri, K. Funato, A. H. Shah, P. D. Stahl, and E. A. Groisman. 1999. A Salmonella virulence protein that inhibits cellular trafficking. EMBO J. 18:3924-3933.
48. Uchiya, K., E. A. Groisman, and T. Nikai. 2004. Involvement of Salmonella pathogenicity island 2 in the up-regulation of interleukin-10 expression in macrophages: role of protein kinase A signal pathway. Infect. Immun. 72: 1964-1973.
49. Vazquez-Torres, A., Y. Xu, J. Jones-Carson, D. W. Holden, S. M. Lucia, M. C. Dinauer, P. Mastroeni, and F. C. Fang. 2000. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287: 1655-1658.
50. Wan, C. P., E. Myung, and B. H. S. Lau. 1993. An automated microfluorometric assay for monitoring oxidative burst activity of phagocytes. J. Immunol. Methods 159:131-138.
51. Wheeldon, A., and C. J. Vardey. 1993. Characterization of the inhibitory prostanoid receptors on human neutrophils. Br. J. Pharmacol. 108:1051-1054.
52. Yu, X.-J., J. Ruiz-Albert, K. E. Unsworth, S. Garvis, M. Liu, and D. W. Holden. 2002. SpiC is required for secretion of Salmonella pathogenicity island 2 type III secretion system proteins. Cell Microbiol. 4:531-540.